SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

USFDA concludes inspection at Solara Active Pharma Sciences’ Cuddalore facility

07 Aug 2023 Evaluate

The United States Food and Drug Administration (USFDA) has concluded an inspection at Solara Active Pharma Sciences’ multiproduct manufacturing facility at Cuddalore. The Agency, with its designated investigators, inspected the Cuddalore facility between July 31, 2023 - August 04, 2023. The inspection established that the facility is in an ‘Acceptable State of Compliance’ with Zero Form 483 inspectional observations from the Agency.

With this successful inspection outcome, the current inspection classification of Cuddalore site shall be reinstated to NAI (No Action Indicated). This facility has also successfully completed the regulatory inspections carried out by the World Health Organization (WHO) between January 23 - 26, 2023 and EU-GMP Inspection carried out jointly by the ‘State Institute for Drug Control (SUKL), Ministry of Health of the Czech Republic’ and ‘National Authority of Medicines and Health Products (INFARMED), Portugal’ between February 07 - 09, 2023.

Solara Active Pharma Sciences is a young, dynamic, entrepreneurial and customer oriented API manufacturer.

Solara Active Pharma Share Price

505.90 16.60 (3.39%)
17-Apr-2026 11:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1681.15
Dr. Reddys Lab 1223.50
Cipla 1239.75
Zydus Lifesciences 945.55
Lupin 2315.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×